In this StockBox interview, we speak with MD Mike Whitlow and Mike Parker, Technical Consultant of ECR Minerals, about the company’s exciting developments across its Australian gold and antimony projects.
Key Highlights:
- A high-grade antimony discovery (32%) at Baillieston driving fresh drilling plans.
- Blue Mountain moving toward trial mining with gold production targeted by year-end.
- Global antimony price surge boosts the value of ECR’s strategic assets.
- With a clear roadmap to revenue and strong tailwinds in the commodity market, ECR Minerals is positioning itself for a pivotal year ahead.
Here is an extract from comments made by Chairman Nick Tulloch in the Annual Report and Accounts for FY 2024:
“During 2024 we have significantly advanced our assets across the group through an acceleration of pace and a diligent assessment of our portfolio. These efforts have produced considerable opportunity – promising results from Tambo, Lolworth and Creswick give us plenty of follow up opportunities but it is perhaps Blue Mountain, where we have the opportunity to commence production later in the year, that provides the nearest revenue opportunity.
Finally, my thanks to our shareholders for supporting us. There is considerable cause for optimism as we enter 2025. We will continue to investigate the potential to bring Blue Mountain into production, whilst also advancing our other assets. Alongside that our policy of keeping a tight rein on costs is unchanged. I look forward to reporting back to you with further progress.”
Financial Summary for Year Ending 30 September 2024
For the year to 30 September 2024, the Group recorded a total comprehensive loss attributable to shareholders of the Company of £1,183,181, a decrease compared with £1,772,670 for the year to 30 September 2023. The largest contributor to the total comprehensive loss was the administrative expenses.
The Group’s net assets as at 30 September 2024 were £5,240,546 in comparison with £5,012,403 at 30 September 2023.See below for detailed financial statements and the Chairman’s review for the period ended 30 September 2024.
